Illumina Ventures is an independently managed venture capital firm specializing in genomics and precision health investments. Established in 2016, the firm focuses on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. Their strategic partnership with Illumina, Inc.

(NASDAQ: ILMN) provides access to the expertise and vision of the world's leading genomics solutions provider. This collaboration enables Illumina Ventures to identify and build companies that will transform healthcare and the world. The firm's investment areas include life science tools, diagnostics, therapeutics, digital health, and sustainability.

Through Illumina Ventures Labs, they offer capital, sequencing, mentorship, and fully equipped genomics lab capabilities to accelerate value creation for early-stage genomics startups.